BriefTea
Every story in sixty words
Health · 5 August 2026
Researchers are inviting people in Bradford to trial a new GLP-1 weight loss drug, which is given as a weekly injection. Steven Lindsay, the chief investigator, stated that it might prove more efficacious and produce fewer adverse reactions. Bradford Teaching Hospitals NHS Trust seeks participants aged 18 or above who are either obese or overweight.
Reported by BBC · How we write briefs
Understand this story
What are GLP-1 drugs? What is 'obese or overweight'? Who pays for drug trials? Why trial new drugs?More briefs
HealthCorrecting hearing loss can cut dementia risk by almost half HealthMan changes life after doctor warns liver disease could kill him HealthSweetener used in chewing gum and jam linked to strokes and heart attacks HealthMouth cancer rates up a third in UK, often with no obvious cause HealthBox breathing helps calm stress and reduce anxiety, say experts HealthNHS managers warn spiralling costs could disrupt ADHD and autism care More health stories → Browse all stories →